Delivery Order SPE2DR25D1104-SPE2DR26FK503
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 23, 2025, for the supply of Trulicity 3 mg/0.5 ml pens. The contract carries a ceiling value of $5,723.04 and features firm fixed-price pricing with an ultimate completion date of June 24, 2025. This is an unset-aside, competitively awarded delivery order representing a single-line item pharmaceutical procurement. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 5, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $4,088.04. The award is structured as a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $6,006.00. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. The contract is not set-aside and represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $5,405.40 by the Defense Logistics Agency on September 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract carries a firm fixed price structure with an ultimate completion date of September 12, 2025, and utilizes no set-aside designation. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 31, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. The contract, valued at $9,009, represents a firm fixed-price delivery order with an ultimate completion date of November 3, 2025, and was awarded through open competition with no set-aside designation. The product will be delivered to the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on December 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. The contract, valued at $3,488.88, carries a firm fixed-price structure with an ultimate completion date of December 5, 2025. This delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK503Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,922.70 by the Defense Logistics Agency (DLA) on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract utilized firm fixed-price pricing with no set-aside designation, indicating competitive award. Performance will be completed at the vendor's Conshohocken facility, with an ultimate completion date of November 26, 2025. This delivery order is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC serves military healthcare programs and enables the company to supply a broad range of pharmaceutical products, including specialty medications, vaccines, and medical devices to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Trulicity, a diabetes medication, represents one of many therapeutic categories within the company's extensive federal medical supply portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/24/25 |